Canada's Chinook Therapeutics secures $65 mln in Series A funding

08/23/2019 8:16:00 PM (GMT)

Canadian biotechnology company Chinook Therapeutics, Inc. has landed $65 million in a Series A round of funding.

The financing was conducted by U.S. early and later-stage venture capital firm Versant Ventures.

Additionally, Apple Tree Partners and new investor, Samsara BioCapital, also participated in the funding round.

Chinook Therapeutics is planning to leverage the new capital to discover and develop precision medicines for kidney diseases.

Chinook Therapeutics

All success stories are prepared by Investsize editors which is selecting elite and remarkable information from press releases and anonymous news sources.There is no charge applied for any success stories which is published . Those published success stories are not investment advices and doesnt offer recommendations Alternate Text